Chemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cells
- PMID: 33865426
- PMCID: PMC8052819
- DOI: 10.1186/s12967-021-02822-5
Chemokines and their receptors: predictors of the therapeutic potential of mesenchymal stromal cells
Abstract
Multipotent mesenchymal stromal cells (MSCs) are promising cellular therapeutics for the treatment of inflammatory and degenerative disorders due to their anti-inflammatory, immunomodulatory and regenerative potentials. MSCs can be sourced from a variety of tissues within the body, but bone marrow is the most frequently used starting material for clinical use. The chemokine family contains many regulators of inflammation, cellular function and cellular migration-all critical factors in understanding the potential potency of a novel cellular therapeutic. In this review, we focus on expression of chemokine receptors and chemokine ligands by MSCs isolated from different tissues. We discuss the differential migratory, angiogenetic and immunomodulatory potential to understand the role that tissue source of MSC may play within a clinical context. Furthermore, this is strongly associated with leukocyte recruitment, immunomodulatory potential and T cell inhibition potential and we hypothesize that chemokine profiling can be used to predict the in vivo therapeutic potential of MSCs isolated from new sources and compare them to BM MSCs.
Keywords: Chemokine; Chemokine receptor; Mesenchymal stromal cell; Therapeutic potential; Tissue source.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.Cytotherapy. 2020 Dec;22(12):762-771. doi: 10.1016/j.jcyt.2020.07.010. Epub 2020 Aug 20. Cytotherapy. 2020. PMID: 32828673
-
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets.Blood. 2005 Jul 15;106(2):419-27. doi: 10.1182/blood-2004-09-3507. Epub 2005 Mar 22. Blood. 2005. PMID: 15784733
-
Differential immunomodulation of human mesenchymal stromal cells from various sources in an inflammation mimetic milieu.Cytotherapy. 2022 Feb;24(2):110-123. doi: 10.1016/j.jcyt.2021.09.005. Epub 2021 Nov 2. Cytotherapy. 2022. PMID: 34740526
-
Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches.Eur Cell Mater. 2010 Sep 1;20:121-33. doi: 10.22203/ecm.v020a11. Eur Cell Mater. 2010. PMID: 21249629 Review.
-
Mesenchymal Stromal Cells Derived from Dental Tissues: Immunomodulatory Properties and Clinical Potential.Int J Mol Sci. 2024 Feb 6;25(4):1986. doi: 10.3390/ijms25041986. Int J Mol Sci. 2024. PMID: 38396665 Free PMC article. Review.
Cited by
-
Mesenchymal Stromal Cells from Healthy and Inflamed Human Gingiva Respond Differently to Porphyromonas gingivalis.Int J Mol Sci. 2022 Mar 23;23(7):3510. doi: 10.3390/ijms23073510. Int J Mol Sci. 2022. PMID: 35408871 Free PMC article.
-
Engineered collagen polymeric materials create noninflammatory regenerative microenvironments that avoid classical foreign body responses.Biomater Sci. 2023 May 2;11(9):3278-3296. doi: 10.1039/d3bm00091e. Biomater Sci. 2023. PMID: 36942875 Free PMC article.
-
Microenvironment-optimized gastrodin-functionalized scaffolds orchestrate asymmetric division of recruited stem cells in endogenous bone regeneration.J Nanobiotechnology. 2024 Nov 20;22(1):722. doi: 10.1186/s12951-024-02886-7. J Nanobiotechnology. 2024. PMID: 39563380 Free PMC article.
-
Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes.Mol Aspects Med. 2022 Feb;83:101063. doi: 10.1016/j.mam.2021.101063. Epub 2021 Dec 24. Mol Aspects Med. 2022. PMID: 34961627 Free PMC article. Review.
-
Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges.Signal Transduct Target Ther. 2024 Sep 13;9(1):242. doi: 10.1038/s41392-024-01936-8. Signal Transduct Target Ther. 2024. PMID: 39271680 Free PMC article. Review.
References
-
- Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970;3(4):393–403. - PubMed
-
- Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4(5):267–274. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources